Things may have gone a little quiet on the stock market front for the likes of Omega Diagnostics and Avacta, but the government has once again pointed towards the importance that lateral flow tests will have in unlocking a summer of major events.
Today it has announced that Festival Republic will be the latest promoter to join its Events Research Programme – welcoming 5,000 people to Sefton Park without the need to wear face coverings nor be socially distanced.
This trial will take place on 2 May with negative lateral flow tests key to gaining entry to the event.
Those who plan to attend the gig will have to take a rapid lateral flow tests at a local testing center prior to entry.
They will also be asked to take another test following the event to further gain evidence on the viability of the approach.
Commenting on the announcement was Culture Secretary Oliver Dowden who hopes testing will be pivotal to welcoming people back to gigs for good:
“We’re one step closer to a summer of live events now our science-led programme is underway. Testing different settings and looking at different mitigations is key to getting crowds back safely.
The Sefton Park pilot is an important addition to the programme. After many months without live audiences, Festival Republic are bringing live music back to fans with this very special event and I hope it won’t be too much longer until gigs are back for good.”
The share price of Omega Diagnostics is currently at 80p while Avacta is at 246p.